Hepatitis C virus infection in chronic liver disease and hepatocellular carcinoma in Saudi Arabia
| Autor: | Abdul Mutaal Mohamed Ahmed, Mohamed A. Al Karawi, Sohail Shariq, Awad A. Saeed, Abdel Rahman El Shiekh Mohamed |
|---|---|
| Rok vydání: | 1992 |
| Předmět: |
Adult
Male medicine.medical_specialty Carcinoma Hepatocellular Hepatitis C virus education Saudi Arabia Hepacivirus medicine.disease_cause Chronic liver disease Gastroenterology Liver disease Internal medicine medicine Humans Hepatitis Antibodies Aged Aged 80 and over Hepatology biology business.industry Liver Diseases Liver Neoplasms virus diseases Hepatitis C Middle Aged medicine.disease digestive system diseases Hepatocellular carcinoma Chronic Disease biology.protein Female Antibody business |
| Zdroj: | Journal of Gastroenterology and Hepatology. 7:237-239 |
| ISSN: | 1440-1746 0815-9319 |
| DOI: | 10.1111/j.1440-1746.1992.tb00970.x |
| Popis: | The prevalence of antibody to hepatitis C virus (HCV) was determined in 139 patients with chronic liver disease (CLD) and 42 patients with hepatocellular carcinoma (HCC) during one year at the Riyadh Military Hospital, Saudi Arabia. The anti-HCV was detected in 36 of 96 (37.5%) HBsAg-negative patients with chronic liver disease and six of 43 (13.9%) HBsAg-positive patients with chronic liver disease. In addition, 11 (42.3%) HBsAg-negative hepatocellular carcinoma patients and two of 16 (12.5%) HBsAg-positive hepatocellular patients had antibody to HCV. The anti-HCV prevalence was 1.5% in 4818 healthy blood donors and 1% in 385 antenatal patients. The overall HCV seropositivity of 30.4% in 181 liver disease patients (CLD and HCC) in Saudi Arabia is lower than that reported from European countries. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text